Figure 3
(A) Pre-procedural loading with antiplatelet therapy among non-ST-segment elevation ACS among patients with AF receiving OAC (either VKA or NOAC) prior to admission. Three respondents indicated they did not perform PCI and therefore could not answer this question. (B) Peri-procedural parenteral anticoagulation among non-ST-segment elevation ACS among patients with AF receiving OAC (either VKA or NOAC) prior to admission. Three respondents indicated they did not perform PCI and therefore could not answer this question. ACS, acute coronary syndrome; AF, atrial fibrillation; NOAC, non-vitamin K antagonist oral anticoagulant; OAC, oral anticoagulation; PCI, percutaneous coronary intervention; VKA, vitamin K antagonist.

(A) Pre-procedural loading with antiplatelet therapy among non-ST-segment elevation ACS among patients with AF receiving OAC (either VKA or NOAC) prior to admission. Three respondents indicated they did not perform PCI and therefore could not answer this question. (B) Peri-procedural parenteral anticoagulation among non-ST-segment elevation ACS among patients with AF receiving OAC (either VKA or NOAC) prior to admission. Three respondents indicated they did not perform PCI and therefore could not answer this question. ACS, acute coronary syndrome; AF, atrial fibrillation; NOAC, non-vitamin K antagonist oral anticoagulant; OAC, oral anticoagulation; PCI, percutaneous coronary intervention; VKA, vitamin K antagonist.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close